ASHLEY SCHWASS: Open Payments
NPI 1891190724 · BERKELEY, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,109 in 42 payments from 25 companies in 2025. Trend: 2023 $284 · 2024 $433 · 2025 $1,109
Food & beverage: $934Education: $175
| Company | Payments | Amount |
|---|---|---|
| Astellas Pharma US Inc | 3 | $116 |
| AstraZeneca Pharmaceuticals LP | 4 | $103 |
| SEAGEN INC. | 1 | $84 |
| Janssen Biotech, Inc. | 3 | $82 |
| Novartis Pharmaceuticals Corporation | 3 | $81 |
| Merck Sharp & Dohme LLC | 3 | $77 |
| E.R. Squibb & Sons, L.L.C. | 2 | $52 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $48 |
| GlaxoSmithKline, LLC. | 2 | $47 |
| PFIZER INC. | 2 | $41 |
Products named: KEYTRUDA, OPDIVO, TAGRISSO, JEMPERLI, Xtandi, BRAFTOVI, CARVYKTI, Amtagvi.
Industry payments across CA — which companies pay providers there.
